卓昇有限公司–最專業科學研究供應商
RT-112 was established from the transitional cell carcinoma (histological grade G2) excised from a woman (age unknown) with untreated primary urinary bladder carcinoma in 1973.
ABC-TC0998
RT-112
Human
Tumor Cell Lines
1 vial
Dry Ice
Liquid Nitrogen
Accegen Biotechnology